Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Ferrier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|March 27, 2023
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disordersJessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patientsOlivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Emerging Infectious Diseases|November 27, 2013
Concomitant human infections with 2 cowpox virus strains in related cases, France, 2011Corinne Ducournau, Audrey Ferrier-Rembert, Olivier Ferraris, et al.
NPJ Vaccines|May 1, 2018
A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targetingTiphany Chrun, Sandra Lacôte, Céline Urien, et al.
Infection|January 2, 2021
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strainEmmanuelle Billon-Denis, Audrey Ferrier-Rembert, Annabelle Garnier, et al.
Nature Microbiology|November 7, 2022
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrationsGaëlle Frenois-Veyrat, Franck Gallardo, Olivier Gorgé, et al.
Nature Communications|August 7, 2025
Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate modelCécile Herate, Audrey Ferrier-Rembert, Francis Relouzat, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|March 27, 2023
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disordersJessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patientsOlivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Emerging Infectious Diseases|November 27, 2013
Concomitant human infections with 2 cowpox virus strains in related cases, France, 2011Corinne Ducournau, Audrey Ferrier-Rembert, Olivier Ferraris, et al.
NPJ Vaccines|May 1, 2018
A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targetingTiphany Chrun, Sandra Lacôte, Céline Urien, et al.
Infection|January 2, 2021
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strainEmmanuelle Billon-Denis, Audrey Ferrier-Rembert, Annabelle Garnier, et al.
Nature Microbiology|November 7, 2022
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrationsGaëlle Frenois-Veyrat, Franck Gallardo, Olivier Gorgé, et al.
Nature Communications|August 7, 2025
Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate modelCécile Herate, Audrey Ferrier-Rembert, Francis Relouzat, et al.
Pageof 2